Hollsteen
← Micron

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $421M · 10-Q 0000723125-16-000146 filed Jan 8, 2016Research and development · Q2 FY2016: $403M · 10-Q 0000723125-16-000176 filed Apr 8, 2016Research and development · Q3 FY2016: $382M · 10-Q 0000723125-16-000201 filed Jul 6, 2016Research and development · Q4 FY2016: $411M · derived · 10-K 0000723125-17-000131 filed Oct 26, 2017Research and development · Q1 FY2017: $470M · 10-Q 0000723125-17-000005 filed Jan 9, 2017Research and development · Q2 FY2017: $473M · 10-Q 0000723125-17-000037 filed Mar 28, 2017Research and development · Q3 FY2017: $434M · 10-Q 0000723125-17-000085 filed Jun 30, 2017Research and development · Q4 FY2017: $447M · derived · 10-K 0000723125-18-000092 filed Oct 15, 2018Research and development · Q1 FY2018: $448M · 10-Q 0000723125-17-000166 filed Dec 20, 2017Research and development · Q2 FY2018: $523M · 10-Q 0000723125-18-000036 filed Mar 23, 2018Research and development · Q3 FY2018: $603M · 10-Q 0000723125-18-000065 filed Jun 22, 2018Research and development · Q4 FY2018: $567M · derived · 10-K 0000723125-19-000094 filed Oct 17, 2019Research and development · Q1 FY2019: $611M · 10-Q 0000723125-18-000156 filed Dec 19, 2018Research and development · Q2 FY2019: $601M · 10-Q 0000723125-19-000014 filed Mar 21, 2019Research and development · Q3 FY2019: $606M · 10-Q 0000723125-19-000035 filed Jun 26, 2019Research and development · Q4 FY2019: $623M · derived · 10-K 0000723125-20-000082 filed Oct 19, 2020Research and development · Q1 FY2020: $640M · 10-Q 0000723125-19-000174 filed Dec 20, 2019Research and development · Q2 FY2020: $681M · 10-Q 0000723125-20-000034 filed Mar 26, 2020Research and development · Q3 FY2020: $649M · 10-Q 0000723125-20-000067 filed Jun 29, 2020Research and development · Q4 FY2020: $630M · derived · 10-K 0000723125-21-000065 filed Oct 8, 2021Research and development · Q1 FY2021: $647M · 10-Q 0000723125-21-000012 filed Jan 8, 2021Research and development · Q2 FY2021: $641M · 10-Q 0000723125-21-000032 filed Apr 1, 2021Research and development · Q3 FY2021: $670M · 10-Q 0000723125-21-000052 filed Jul 1, 2021Research and development · Q4 FY2021: $705M · derived · 10-K 0000723125-22-000048 filed Oct 7, 2022Research and development · Q1 FY2022: $712M · 10-Q 0000723125-22-000004 filed Jan 6, 2022Research and development · Q2 FY2022: $792M · 10-Q 0000723125-22-000016 filed Mar 30, 2022Research and development · Q3 FY2022: $773M · 10-Q 0000723125-22-000036 filed Jul 1, 2022Research and development · Q4 FY2022: $839M · derived · 10-K 0000723125-23-000054 filed Oct 6, 2023Research and development · Q1 FY2023: $849M · 10-Q 0000723125-22-000072 filed Dec 22, 2022Research and development · Q2 FY2023: $788M · 10-Q 0000723125-23-000022 filed Mar 29, 2023Research and development · Q3 FY2023: $758M · 10-Q 0000723125-23-000041 filed Jun 29, 2023Research and development · Q4 FY2023: $719M · derived · 10-K 0000723125-24-000027 filed Oct 4, 2024Research and development · Q1 FY2024: $845M · 10-Q 0000723125-23-000077 filed Dec 21, 2023Research and development · Q2 FY2024: $832M · 10-Q 0000723125-24-000007 filed Mar 21, 2024Research and development · Q3 FY2024: $850M · 10-Q 0000723125-24-000019 filed Jun 27, 2024Research and development · Q4 FY2024: $903M · derived · 10-K 0000723125-25-000028 filed Oct 3, 2025Research and development · Q1 FY2025: $888M · 10-Q 0000723125-24-000047 filed Dec 19, 2024Research and development · Q2 FY2025: $898M · 10-Q 0000723125-25-000009 filed Mar 21, 2025Research and development · Q3 FY2025: $965M · 10-Q 0000723125-25-000021 filed Jun 26, 2025Research and development · Q4 FY2025: $1.0B · derived · 10-K 0000723125-25-000028 filed Oct 3, 2025Research and development · Q1 FY2026: $1.2B · 10-Q 0000723125-25-000046 filed Dec 18, 2025Research and development · Q2 FY2026: $1.2B · 10-Q 0000723125-26-000006 filed Mar 19, 2026Research and development · Q3 FY2026: $1.3B · 10-Q 0000723125-26-000015 filed Jun 25, 2026705a1,316421Q1 FY2016Q3 FY2026Q4 FY2021
$MResearch and development · Q4 FY2020: $630M · derived · 10-K 0000723125-21-000065 filed Oct 8, 2021Research and development · Q1 FY2021: $647M · 10-Q 0000723125-21-000012 filed Jan 8, 2021Research and development · Q2 FY2021: $641M · 10-Q 0000723125-21-000032 filed Apr 1, 2021Research and development · Q3 FY2021: $670M · 10-Q 0000723125-21-000052 filed Jul 1, 2021Research and development · Q4 FY2021: $705M · derived · 10-K 0000723125-22-000048 filed Oct 7, 2022Research and development · Q1 FY2022: $712M · 10-Q 0000723125-22-000004 filed Jan 6, 2022Research and development · Q2 FY2022: $792M · 10-Q 0000723125-22-000016 filed Mar 30, 2022Research and development · Q3 FY2022: $773M · 10-Q 0000723125-22-000036 filed Jul 1, 2022705a773630a792Q4 FY2020Q3 FY2022Q4 FY2021
Q4 FY2021
705a$M
derived
All values (43)
PeriodValue ($M)Status
Q3 FY20261,316reported
Q2 FY20261,250reported
Q1 FY20261,171reported
Q4 FY20251,047derived
Q3 FY2025965reported
Q2 FY2025898reported
Q1 FY2025888reported
Q4 FY2024903derived
Q3 FY2024850reported
Q2 FY2024832reported
Q1 FY2024845reported
Q4 FY2023719derived
Q3 FY2023758reported
Q2 FY2023788reported
Q1 FY2023849reported
Q4 FY2022839derived
Q3 FY2022773reported
Q2 FY2022792reported
Q1 FY2022712reported
Q4 FY2021705derived
Q3 FY2021670reported
Q2 FY2021641reported
Q1 FY2021647reported
Q4 FY2020630derived
Q3 FY2020649reported
Q2 FY2020681reported
Q1 FY2020640reported
Q4 FY2019623derived
Q3 FY2019606reported
Q2 FY2019601reported
Q1 FY2019611reported
Q4 FY2018567derived
Q3 FY2018603reported
Q2 FY2018523reported
Q1 FY2018448reported
Q4 FY2017447derived
Q3 FY2017434reported
Q2 FY2017473reported
Q1 FY2017470reported
Q4 FY2016411derived
Q3 FY2016382reported
Q2 FY2016403reported
Q1 FY2016421reported

CSV with all sources · Technical ID: rnd

More metrics for Micron

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$705M (derived)
Period
Q4 FY2021, ended Sep 2, 2021 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 2,663M − 1,958M = $705M (FY value from 10-K 0000723125-22-000048; 9-month value from the Q3-10-Q)
Source
10-K, filed Oct 7, 2022 · 0000723125-22-000048
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$705MOct 7, 202210-K 0000723125-22-000048derived · confidence 1. · current